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Moonlighting Proteins
Constance Jeffery1, Matt Mani2, Vaishak Amblee1, Chang Chen2.
1Biological Sciences, University of Illinois, Chicago, IL, USA,
2Bioengineering, University of Illinois, Chicago, IL, USA.
Moonlighting proteins comprise a class ofmultifunctional proteins inwhich a sin-
gle polypeptide chain has multiple biochemical functions that are not due to gene
fusion events. Examples include cytosolic enzymes that are also transcription fac-
tors, crystallins, chaperones, extracellular growth factors, or cell surface adhesins.
The variety of knownmoonlighting proteins, themultiple ways inwhich one pro-
tein can have multiple functions, the potential benefits to the organism of
combining two functions in one protein, and the methods proposed for a protein
to evolve a second function suggest thatmoonlightingproteinsmight be common.
The ability of a protein to moonlight in different multi-protein complexes or
pathways can complicate the prediction of protein function from sequence or
structure and the annotation of sequence databases. To date, most moonlighting
functions have been found by serendipity. There is currently no straightforward
method to identify which proteins moonlight, or for determining if a protein of
interest is a moonlighting protein. In addition, sequence homologues of moon-
lighting proteins often do not perform both functions. We are using biochem-
ical methods and X-ray crystallography to study individual moonlighting
proteins. We are also organizing information about the sequences, structures,
functions and functional sites of the over 200 known moonlighting proteins
into the web-based MoonProt database.
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Thiol Labeling Reveals Presence of Cryptic Binding Sites in b-Lactamase
Eric Bolin, Brendan Maguire, Gregory Bowman, Susan Marqusee.
University of California, Berkeley, Berkeley, CA, USA.
The field of drug design has for many years sought to design ligands for known
binding pockets in proteins. Cryptic binding sites, which are unexpected open-
ings that are invisible to normal experimental methods but can modulate activ-
ity through communication with the active site, have the ability to greatly
expand the number of proteins whose behavior and activity can be easily modu-
lated by increasing the number of druggable sites. Recent work has offered the
possibility of identifying these sites from molecular dynamics simulations of
proteins in the absence of ligands, allowing identification of sites for many li-
gands to be screened in a single experiment. To experimentally verify these
computational models, we have tested b-lactamase for the presence of cryptic
binding sites. We have employed a method using mutagenesis and thiol label-
ing to verify the transient opening of cryptic sites as well as the ability of a
large, covalent adduct at these sites to alter activity of the protein. This has
led us to conclude that conformations with transiently open pockets exist in
equilibrium with the known structure under native conditions, and these
pockets may be suitable for future drug design studies.
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Structural Dynamics Studies of Fatty Acid Binding Protein-4 by Solution
NMR Spectroscopy
Adedolapo Ojoawo, Choua Xiong, Kim N. Ha.
Chemistry and Biochemistry, St. Catherine University, St. Paul, MN, USA.
Adipocyte fatty acid binding protein-4 (FABP4) is a 132-aa intracellular lipid
binding protein involved in the transport of fatty acids between cell membranes
and organelles. FABP4 participates in several pathways including lipolysis and
lipogenesis, and is involved in lipid and energy metabolism related diseases
such as diabetes. Although the x-ray structure of FABP4 has been determined
and binding to several of its hydrophobic ligands well characterized, the tran-
sitions in the structural dynamics upon ligand binding has yet to be determined.
Here, solution NMR experiments will be carried out on 15N and 13C labeled
FABP4 to study the structural transitions between its free and bound states.
Spin relaxation measurements will also be used to reveal any changes that
occur upon binding of FABP4 to its hydrophobic ligands.
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Insights into the Cyclic Nucleotide Selectivity Mechanism of Cyclic GMP
Dependent Protein Kinase II
James Campbell1, Gilbert Huang1, Albert Reger1, Todd Link2,
John Ladbury2, Choel Kim1.
1Pharmacology, Baylor College of Medicine, Houston, TX, USA,
2Department of Biochemistry and Molecular Biology, The University of
Texas MD Anderson Cancer Center, Houston, TX, USA.
Membrane bound type II cGMP dependent protein kinase (PKG II) is a central
mediator of cGMP signaling cascade, which regulates circadian rhythmicity,intestinal water secretion, bone growth and renal functions. PKG II contains
an N-terminal regulatory (R)-domain, and a C-terminal catalytic (C)-domain.
The R-domain contains tandem cyclic nucleotide binding domains (CNB-A
and B) each with different affinities for cGMP, the second messenger that reg-
ulates kinase activity of PKG II. While it is known that PKG II needs to be high-
ly selective for cGMP over cAMP to function properly, little is known about its
cyclic nucleotide selectivity and the selectivity’s role in activation. To under-
stand its cyclic nucleotide selectivity and activation mechanism of PKG II,
we first identified CNB-B to be highly selective for cGMP and solved its crystal
structure with cGMP. The complex structure revealed that PKG II utilizes an
arginine and two aspartate residues on the C-terminal helix to recognize the
guanine moiety in cGMP. This is completely different from PKG I, where a
conserved arginine from the b barrel of CNB-B specifically binds the guanine
moiety of cGMP and imparts cyclic nucleotide selectivity. We are currently
testing the roles of PKG II specific interactions in cGMP selectivity and activa-
tion of PKG II.
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Effects of Ligand Binding on the Rigidity and Mobility of Proteins: An
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Jack Heal1, Claudia Blindauer2, Robert B. Freedman3, Rudolf Roemer4.
1School of Life Sciences and Institute of Advanced Studies, University of
Warwick, Coventry, United Kingdom, 2Department of Chemistry, University
of Warwick, Coventry, United Kingdom, 3School of Life Sciences,
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Cyclophilin A is an enzyme which plays a role in the folding of proteins. It also
binds to and aids the function of the immunosuppressant drug cyclosporin A as
well as binding to the HIV-1 capsid protein.
We expand upon a method recently used in our study of HIV-1 protease and use
the computational tools FIRST and FRODA to model the flexibility and motion
of cyclophilin A in the presence and absence of its principal ligands.
In order to verify the simulation process, we have also conducted hydrogen-
deuterium exchange NMR (HDX) experiments, the results of which are also
presented.
The computational procedure is far quicker than more in-depth approaches
such as molecular dynamics, yet it yields results which are comparable with
experimental data, on a timescale of CPU-minutes.
We use the computational tools FIRST and FRODA to model the flexibility and
motion of cyclophilin A in order to predict the results of hydrogen-deuterium
exchange NMR (HDX) experiments.
The rigidity analysis software FIRST can be used to predict the "folding cores"
of proteins identified as slowly exchanging residues in HDX. This prediction is
improved using the protein mobility software FRODA.
We are using these methods to investigate the effect of ligand binding on cyclo-
philin A computationally and experimentally.
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Bridging Simulations and Calorimetry: Computational Studies of Binding
Thermodynamics and Entropy-Enthalpy Transduction
Michael K. Gilson1, Andrew T. Fenley1, Hari Muddana2.
1Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD, La Jolla,
CA, USA, 2Dart Neurosciences, LLC, San Diego, CA, USA.
Molecular simulations are now fast enough that we can begin to make connec-
tions to the thermodynamic data provided by isothermal titration calorimetry.
Here, I will describe the thermodynamic analysis of a millisecond-duration pro-
tein simulation. A central result is that local perturbations of a protein, due, for
example, to binding of small molecules, may easily induce global conforma-
tional shifts with large associated shifts in entropy and enthalpy. Thus, the
global conformational shifts can effectively transduce local binding thermody-
namics into quite different overall apparent thermodynamics. This phenome-
non, which may be termed entropy-enthalpy transduction, likely occurs in
many systems, and could make measured entropies and enthalpies of binding
unreliable indicators of binding forces. Entropy-enthalpy transduction may
also help explain the high experimental variance of measured enthalpies and
entropies relative to free energies, and may underly many cases of entropy-
enthalpy compensation.
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Differential Responses of Msh2/6 and Damaged DNA Probed byMolecular
Dynamics
Freddie R. Salsbury, Jr, Lacramioara Negureanu.
Wake Forest University, Winston Salem, NC, USA.
Over the past decade, there has been a growing interest in studying the binding
of DNA to the MutSalpha protein complex. This heterodimeric protein com-
plex, the Msh2/Msh6 complex in humans, is the initial complex that can
